15. Inclusion body myositis
39 clinical trials, 32 drugs (DrugBank: 11 drugs), 11 drug target genes, 119 drug target pathways
Searched query = "Inclusion body myositis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02317094 (ClinicalTrials.gov) | January 2015 | 10/12/2014 | Blood-flow Restricted Exercise in Inclusion Body Myositis | Low-intensity Blood-flow Restricted Muscle Exercise in Patients With Sporadic Inclusion Body Myositis: a Randomised Controlled Trial | Sporadic Inclusion Body Myositis | Other: Blood-flow restricted training;Drug: Care as usual | University of Southern Denmark | Odense University Hospital | Completed | 35 Years | N/A | Both | 22 | N/A | Denmark |